Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Gray

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
JHEP Reports : Innovation in Hepatology|November 11, 2024
A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessnessAdele Mourad, Rona McGeer, Emma Gray, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 22, 2025
FPHC Wellbeing Charter: The 'Whys' and 'Hows' of the CharterSarah Morton, Katy Surman, Richard Bayliss, et al.
Antiviral Therapy|April 30, 2015
Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individualsLinh Thuy Nguyen, Emma Gray, Jonathan Dean, et al.
Respiratory Medicine|August 18, 2025
Higher mortality in Extracorporeal Membrane Oxygenation patients during the COVID-19 pandemic compared with H1N1 influenza: implications for future pandemicsHarriet J Caterson, Lauren Troy, Moin Ahmed, et al.
Immunotherapy|July 7, 2022
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancerMin Huang, Peter Fasching, Amin Haiderali, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing involvement of people with multiple sclerosis in clinical trial designEmma Gray, Anneesa Amjad, Jenny Robertson, et al.
Neurology|March 24, 2022
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple SclerosisVivien Li, Baptiste Leurent, Frederik Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
The first global landscape analysis of multiple sclerosis research fundingBruce Bebo, Tim Coetzee, Emma Gray, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportHelmut Butzkueven, Sofia Arkelsten, Giancarlo Comi, et al.
Ebiomedicine|February 8, 2025
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's diseaseJeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
JHEP Reports : Innovation in Hepatology|November 11, 2024
A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessnessAdele Mourad, Rona McGeer, Emma Gray, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 22, 2025
FPHC Wellbeing Charter: The 'Whys' and 'Hows' of the CharterSarah Morton, Katy Surman, Richard Bayliss, et al.
Antiviral Therapy|April 30, 2015
Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individualsLinh Thuy Nguyen, Emma Gray, Jonathan Dean, et al.
Respiratory Medicine|August 18, 2025
Higher mortality in Extracorporeal Membrane Oxygenation patients during the COVID-19 pandemic compared with H1N1 influenza: implications for future pandemicsHarriet J Caterson, Lauren Troy, Moin Ahmed, et al.
Immunotherapy|July 7, 2022
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancerMin Huang, Peter Fasching, Amin Haiderali, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing involvement of people with multiple sclerosis in clinical trial designEmma Gray, Anneesa Amjad, Jenny Robertson, et al.
Neurology|March 24, 2022
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple SclerosisVivien Li, Baptiste Leurent, Frederik Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
The first global landscape analysis of multiple sclerosis research fundingBruce Bebo, Tim Coetzee, Emma Gray, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportHelmut Butzkueven, Sofia Arkelsten, Giancarlo Comi, et al.
Ebiomedicine|February 8, 2025
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's diseaseJeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
Pageof 7